Credit: The University of Texas at El Paso.
Renato Aguilera, Ph.D., a professor in the Department of Biological Sciences, is the principal investigator on a project that identified a novel pharmaceutical compound that successfully kills leukemia and lymphoma cancer cells, potentially paving the way for new forms of therapy. His team’s findings were recently published in the research journal PLOS One.